Intra-arterial rhenium-188 lipiodol in the treatment of inoperable hepatocellular carcinoma: results of an IAEA-sponsored multination study

P Bernal, JL Raoul, G Vidmar, E Sereegotov… - International Journal of …, 2007 - Elsevier
PURPOSE: Intra-arterial injections (IAI) of 131I-lipiodol is effective in treating hepatocellular
carcinoma patients, but is expensive and requires a 7-day hospitalization in a
radioprotection room. 188Re is inexpensive, requires no patient isolation, and can be used
with lipiodol. METHODS AND MATERIALS: This International Atomic Energy Agency–
sponsored phase II trial aimed to assess the safety and the efficacy of a radioconjugate
188Re+ lipiodol (188Re-Lip) in a large cohort of hepatocellular carcinoma patients from …
以上显示的是最相近的搜索结果。 查看全部搜索结果